Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone Infusion for Vasospasm Treatment in Subarachnoid Hemorrhage
NCT04362527Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Aug 2020
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cerebral vasospasm comparing Milrinone with Placebo (2 arms). Primary endpoint: Proportion of patients with a good outcome (modified Rankin Score <= 2) at 3 months. Started Aug 2020; status: completed.
02
Drugs
milrinone
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT04362527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362527.